Edgene Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 2

Edgene General Information

Description

Operator of a gene-correction firm intended to address mitochondrial-targeted genetic disorders. The company focuses on developing therapies for mitochondrial deoxyribonucleic acid mutations, enabling patients to access potential treatment options for genetic conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Songdo Mirae-ro 30
  • Didong 909-1-7 (Songdo-dong, Smart Valley Knowledge Industry Center)
  • Incheon, Yeonsu-gu
  • South Korea
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • Songdo Mirae-ro 30
  • Didong 909-1-7 (Songdo-dong, Smart Valley Knowledge Industry Center)
  • Incheon, Yeonsu-gu
  • South Korea

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Edgene Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Accelerator/Incubator 04-Nov-2026 Completed Startup
2. Seed Round 01-Sep-2023 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Edgene’s complete valuation and funding history, request access »

Edgene Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Edgene Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Genaxis (Korea) Venture Capital Minority
Myriad Life Sciences Accelerator/Incubator Minority
To view Edgene’s complete investors history, request access »

Edgene FAQs

  • When was Edgene founded?

    Edgene was founded in 2022.

  • Where is Edgene headquartered?

    Edgene is headquartered in Incheon, South Korea.

  • What is the size of Edgene?

    Edgene has 13 total employees.

  • What industry is Edgene in?

    Edgene’s primary industry is Biotechnology.

  • Is Edgene a private or public company?

    Edgene is a Private company.

  • What is Edgene’s current revenue?

    The current revenue for Edgene is .

  • Who are Edgene’s investors?

    Genaxis (Korea) and Myriad Life Sciences have invested in Edgene.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process